학술논문
Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing 177 Lu-PSMA-617 radioligand therapy
Document Type
Article
Author
Source
In: European Journal of Nuclear Medicine and Molecular Imaging . (European Journal of Nuclear Medicine and Molecular Imaging, January 2021, 48(1):103-112)
Subject
Language
English
ISSN
16197089
16197070
16197070